April 2014
Volume 55, Issue 13
ARVO Annual Meeting Abstract  |   April 2014
Polyethylene Glycol (PEG) Induced Mouse Model of Dry Age Related Macular Degeneration (AMD)
Author Affiliations & Notes
  • Valeriy V Lyzogubov
    Ophthalmology, Jones Eye Institute - UAMS, Little Rock, AR
  • Nalini S Bora
    Ophthalmology, Jones Eye Institute - UAMS, Little Rock, AR
  • Puran S Bora
    Ophthalmology, Jones Eye Institute - UAMS, Little Rock, AR
  • Footnotes
    Commercial Relationships Valeriy Lyzogubov, None; Nalini Bora, None; Puran Bora, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 1181. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Valeriy V Lyzogubov, Nalini S Bora, Puran S Bora; Polyethylene Glycol (PEG) Induced Mouse Model of Dry Age Related Macular Degeneration (AMD). Invest. Ophthalmol. Vis. Sci. 2014;55(13):1181.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Age-related macular degeneration (AMD) is a leading cause of irreversible blindness worldwide. Understanding the mechanisms responsible for dry AMD during its initial phases will be highly beneficial in designing new therapeutic strategies for the treatment of dry AMD. The aim of this study was to characterize dry AMD-like changes in mouse RPE and retina after PEG treatment.

Methods: We injected male C57BL/6 mice subretinally with PBS, 0.025, 0.25, 0.5 and 1.0 mg of PEG-400 and the animals were sacrificed on day 5. Eyes were harvested and processed for histological analysis. In all other experiments 0.5 mg PEG was injected and animals were sacrificed on days 1, 3, 5 or 14. Paraffin sections were used for TUNEL staining. Immunofluorescent staining using paraffin sections were utilized to detect active Caspase 3 (Casp3act), Atg12 and proliferating cell nuclear antigen. Plastic sections were analyzed using light and electron microscopy. Measurement and quantification of morphometric parameters were performed using ImageJ program. Gene expression was studied in PEG injected eyes and PBS controls using RNA microarray.

Results: Subretinal injection of 0.5 mg PEG caused a 32% reduction of outer nuclear layer (ONL) thickness, 61% decrease of photoreceptor outer and inner segment length, 49% decrease of nuclear density in the ONL and 31% increase of RPE cell density by day 5 post-injection. Maximum TUNEL positive nuclei in the ONL were detected at day 5 after PEG injection. Histological signs of apoptosis were observed in the ONL by light and electron microscopy. Degeneration, autophagy and proliferation of RPE cells was noted in PEG injected eyes. RNA microarray demonstrated that several genes including Mmp9, Htra1, Casp1, Lgals3, C3, Serping1, Cfi, Lpl, Cp, fgf2 were up-regulated in PEG injected eyes compared to PBS controls.

Conclusions: Intraocular administration of PEG leads to morphological changes in RPE and retina consistent with dry AMD. Furthermore, PEG treatment up-regulated several genes reported to be involved in human AMD. Collectively, these results suggest that this simple and fast model will be useful to investigate dry AMD pathogenesis and treatment.

Keywords: 412 age-related macular degeneration • 701 retinal pigment epithelium • 637 pathology: experimental  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.